Abstract
Semaphorins are cell surface and soluble signals that control axonal guidance1,2. Recently, semaphorin receptors (plexins) have been discovered and shown to be widely expressed3,4,5. Their biological activities outside the nervous system and the signal transduction mechanism(s) they utilize are largely unknown. Here, we show that in epithelial cells, Semaphorin 4D (Sema 4D) triggers invasive growth, a complex programme that includes cell–cell dissociation, anchorage-independent growth and branching morphogenesis6. Interestingly, the same response is also controlled by scatter factors through their tyrosine kinase receptors, which share striking structural homology with plexins in their extracellular domain 3. We found that in cells expressing the endogenous proteins, Plexin B1 (the Sema 4D Receptor) and Met (the Scatter Factor 1/ Hepatocyte Growth Factor Receptor) associate in a complex. In addition, binding of Sema 4D to Plexin B1 stimulates the tyrosine kinase activity of Met, resulting in tyrosine phosphorylation of both receptors. Finally, cells lacking Met expression do not respond to Sema 4D unless exogenous Met is expressed. This work identifies a novel biological function of semaphorins and suggests the involvement of an unexpected signalling mechanism, namely, the coupling of a plexin to a tyrosine kinase receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tessier-Lavigne, M. & Goodman, C. S. Science 274, 1123–1133 (1996).
Raper, J. A. Curr. Opin. Neurobiol. 10, 88–94 (2000).
Winberg, M. L. et al. Cell 95, 903–916 (1998).
Tamagnone, L. et al. Cell 99, 71–80 (1999).
Takahashi, T. et al. Cell 99, 59–69 (1999).
Trusolino, L. & Comoglio, P. M. Nature Rev. Cancer 2, 289–300 (2002).
Christensen, C. R. et al. Cancer Res. 58, 1238–1244 (1998).
Maestrini, E. et al. Proc. Natl Acad.Sci.USA 93, 674–678 (1996).
Giordano, S., Ponzetto, C., Di Renzo, M. F., Cooper, C. S. & Comoglio, P. M. Nature 339, 155–156 (1989).
Tamagnone, L. & Comoglio, P. M. Trends Cell Biol. 10, 377–383 (2000).
Montesano, R., Scaller, G. & Orci, L. Cell 66, 697–711 (1991).
Ebens, A. et al. Neuron 17, 1157–1172 (1996).
Maina, F. Hilton, M. C., Ponzetto, C., Davies, A. M. & Klein, R. Genes Dev. 11, 3341–3350 (1997).
Kolodkin, A. L., Matthes, D. J. & Goodman, C. S. Cell 75, 1389–1399 (1993).
Semaphorin Nomenclature Committee Cell 97, 551–552 (1999).
Elhabazi, A., Delaire, S., Bensussan, A., Boumsell, L. & Bismuth, G. J. Immunol. 166, 4341–4347 (2001).
Kumanogoh, A. et al. Cell, 13 621–631 (2000).
Medico, E. et al. Mol. Biol. Cell 7, 495–504 (1996).
Sachs, M. et al. J. Cell Biol. 133, 1095–1107 (1996).
Ponzetto, C. et al. Cell 77, 261–271 (1994).
Weidner, K. M. et al. Nature 384, 173–176 (1996).
Morotti, A., Mila, S., Accornero, P., Tagliabue, E. & Ponzetto, C. Oncogene 21, 4885–4893 (2002).
Bardelli, A., Longati, P., Williams, T. A., Benvenuti, S. & Comoglio, P. M. J. Biol. Chem. 274, 29274–29281 (1999).
Nakamura, F., Kalb, R. G. & Strittmatter, S. M. J. Neurobiol. 44, 219–229 (2000).
Trusolino, L., Bertotti, A. & Comoglio, P. M. Cell 107, 643–654 (2001).
Birchmeier, W. et al. Ciba Found. Symp. 212, 230–240 (1997).
Di Renzo, M. F. et al. Oncogene 19, 1547–1555 (2000).
Giordano, S. et al. FASEB J. 14, 401 –408 (2000).
Ponzetto, C. et al. J. Biol. Chem. 271, 14119–14123 (1996).
Prat, M., Crepaldi, T., Pennacchietti, S., Bussolino, F. & Comoglio, P. M. J. Cell Sci. 111, 237–247 (1998).
Acknowledgements
We thank P. Gual for suggestions and helpful discussions and S. Anguissola for providing MLP29 cells expressing exogenous Plexin B1. We are grateful to M. Geuna and L. Granziero for performing FACS analysis and cell sorting, to S. Gamberini for providing the Trk–Sep chimaera, to T. Nagase for the Plexin D1 cDNA and to L. Naldini for the lentiviral vector p156RRLsinPPThCMVMCSpre. The excellent technical assistance of L. Palmas and R. Albano is gratefully acknowledged. We thank A. Cignetto for secretarial help and E. Wright for editing the manuscript. This work was supported by grants from the Associazione Italiano Ricerca sul Cancro, BIOMED EC and the Harvard-Armenise Foundation grants (P.M.C.) from Telethon-Italy (grant E1129 to L.T.) and from MURST COFIN (S.G). S.A. is recipient of a Federazione Italiano Ricerca sul Cancro fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary figures
Figure S1 (PDF 243 kb)
Figure S2
Figure S3
Rights and permissions
About this article
Cite this article
Giordano, S., Corso, S., Conrotto, P. et al. The Semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 4, 720–724 (2002). https://doi.org/10.1038/ncb843
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb843
This article is cited by
-
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer
Scientific Reports (2024)
-
B-type Plexins promote the GTPase activity of Ran to affect androgen receptor nuclear translocation in prostate cancer
Cancer Gene Therapy (2023)
-
SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling
Journal of Translational Medicine (2022)
-
A receptor-antibody hybrid hampering MET-driven metastatic spread
Journal of Experimental & Clinical Cancer Research (2021)
-
MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1–cMET signaling
Oncogene (2021)